97 related articles for article (PubMed ID: 23900681)
1. In vivo and in vitro inhibition of human liver cancer progress by downregulation of the μ-opioid receptor and relevant mechanisms.
Lu J; Liu Z; Zhao L; Tian H; Liu X; Yuan C
Oncol Rep; 2013 Oct; 30(4):1731-8. PubMed ID: 23900681
[TBL] [Abstract][Full Text] [Related]
2. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MKK7-JNK by the TOR signaling pathway regulator-like protein contributes to resistance of HCC cells to TRAIL-induced apoptosis.
Song IS; Jun SY; Na HJ; Kim HT; Jung SY; Ha GH; Park YH; Long LZ; Yu DY; Kim JM; Kim JH; Ko JH; Kim CH; Kim NS
Gastroenterology; 2012 Nov; 143(5):1341-1351. PubMed ID: 22841785
[TBL] [Abstract][Full Text] [Related]
4. Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium.
Tang B; Du J; Wang J; Tan G; Gao Z; Wang Z; Wang L
Oncol Rep; 2012 Apr; 27(4):1090-6. PubMed ID: 22159816
[TBL] [Abstract][Full Text] [Related]
5. Protection of rat intestinal epithelial cells from ischemia/reperfusion injury by (D-Ala2, D-Leu5)-enkephalin through inhibition of the MKK7-JNK signaling pathway.
Wang Z; Tang B; Tang F; Li Y; Zhang G; Zhong L; Dong C; He S
Mol Med Rep; 2015 Sep; 12(3):4079-4088. PubMed ID: 26126577
[TBL] [Abstract][Full Text] [Related]
6. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
7. Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling.
Belcheva MM; Tan Y; Heaton VM; Clark AL; Coscia CJ
Mol Pharmacol; 2003 Dec; 64(6):1391-401. PubMed ID: 14645669
[TBL] [Abstract][Full Text] [Related]
8. The μ-opioid receptor (MOR) promotes tumor initiation in hepatocellular carcinoma.
Li Y; Li G; Tao T; Kang X; Liu C; Zhang X; Wang C; Li C; Guo X
Cancer Lett; 2019 Jul; 453():1-9. PubMed ID: 30928385
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
Lennon FE; Mirzapoiazova T; Mambetsariev B; Salgia R; Moss J; Singleton PA
Anesthesiology; 2012 Apr; 116(4):857-67. PubMed ID: 22343475
[TBL] [Abstract][Full Text] [Related]
10. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
11. CDCA7L promotes hepatocellular carcinoma progression by regulating the cell cycle.
Tian Y; Huang C; Zhang H; Ni Q; Han S; Wang D; Han Z; Li X
Int J Oncol; 2013 Dec; 43(6):2082-90. PubMed ID: 24141559
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer.
Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Chang YG; Kim MG; Park WS; Lee JY; Lee SY; Chu IS; Nam SW
Hepatology; 2012 Aug; 56(2):644-57. PubMed ID: 22392728
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
Fang EF; Zhang CZ; Zhang L; Fong WP; Ng TB
Int J Biochem Cell Biol; 2012 Aug; 44(8):1351-60. PubMed ID: 22554586
[TBL] [Abstract][Full Text] [Related]
14. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: new insight into the presence of the transcript variant of MUC4.
Xie K; Zhi X; Tang J; Zhu Y; Zhang J; Li Z; Tao J; Xu Z
Oncol Rep; 2014 May; 31(5):2187-94. PubMed ID: 24676527
[TBL] [Abstract][Full Text] [Related]
16. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
[TBL] [Abstract][Full Text] [Related]
17. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
[TBL] [Abstract][Full Text] [Related]
18. Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway.
Huang G; Tang B; Tang K; Dong X; Deng J; Liao L; Liao Z; Yang H; He S
Oncol Rep; 2014 May; 31(5):2377-84. PubMed ID: 24676882
[TBL] [Abstract][Full Text] [Related]
19. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
[TBL] [Abstract][Full Text] [Related]
20. Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma.
Gorur A; Patiño M; Takahashi H; Corrales G; Pickering CR; Gleber-Netto FO; Myers JN; Cata JP
Life Sci; 2021 Aug; 278():119541. PubMed ID: 33930368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
